Concepedia

Andrew K. Mason

AK

Statistics

Publications

8

Citations

393

H-Index

8

Active since

1999

Affiliations

BD Biosciences (United States)(Current)

Rensselaer Polytechnic Institute

Andrew K. Mason is an author at BD Biosciences (United States) specializing in medicine, pharmacology, and enzyme inhibition.

Publications per year

1999–2018

8

Publications

8

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 150 citations · Full text

, , +9

Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC<sub>50</sub>shift approach facilitates<i>k</i><sub>inact</sub>assay design

Elke S. Perloff, Andrew K. Mason, Shangara S. Dehal et al. · Xenobiotica · 2009 · 87 citations

, , +17

Sequential Metabolism of AMG 487, a Novel CXCR3 Antagonist, Results in Formation of Quinone Reactive Metabolites That Covalently Modify CYP3A4 Cys239 and Cause Time-Dependent Inhibition of the Enzyme

Kirk R. Henne, Thuy Tran, Brooke M. VandenBrink et al. · Drug Metabolism and Disposition · 2012 · 41 citations · Full text

, , +17

The Application of Ultrasound as a Pre-Treatment for Anaerobic Digestion

J. Quarmby, J. R. Scott, Andrew K. Mason et al. · Environmental Technology · 1999 · 39 citations

, , +16

Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole

David M. Stresser, Elke S. Perloff, Andrew K. Mason et al. · Drug Metabolism and Disposition · 2016 · 24 citations

, , +15

1–5 of 8